Literature DB >> 18650200

NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus.

Martin Huelsmann1, Stephanie Neuhold, Guido Strunk, Deddo Moertl, Rudolf Berger, Rudolf Prager, Heidemarie Abrahamian, Michaela Riedl, Richard Pacher, Anton Luger, Martin Clodi.   

Abstract

AIMS: This study evaluated the predictive value of NT-proBNP for patients with diabetes mellitus and compared the prognostic aptitude of this neurohumoral marker to traditional markers of cardiovascular events. METHODS AND
RESULTS: A prospective observational study was conducted in 631 diabetic patients. The composite endpoint consisted of unplanned hospitalization for cardiovascular events or death within the observation period of 12 months. Of all variables analysed (age, gender, history of hypertension, ischaemic heart disease/any cardiac disease, smoking, duration of diabetes, body mass index, blood pressure, New York Heart Association-class, Dyspnoea score, Minnesota Living with Heart Failure Questionnaire, LDL-cholesterol, HbA(1c), creatinine, glomerular filtration rate), the logarithm of NT-proBNP gave the most potent information in a stepwise Cox regression analysis (P < 0.0001). Bootstrapping with 500 samples supports this result in 95% samples. The negative predictive value of a normal value (<125 pg/mL) of NT-proBNP for short-term cardiovascular events in diabetic patients is 98%.
CONCLUSION: We have demonstrated a strong and independent correlation between NT-proBNP and short-term prognosis of cardiovascular events for patients with diabetes mellitus. With a high negative predictive value it can identify individuals who are not at intermediate risk for cardiovascular events. NT-proBNP proved to be of higher predictive value than traditional cardiovascular markers, in this unselected cohort.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18650200     DOI: 10.1093/eurheartj/ehn334

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  15 in total

Review 1.  [Diabetes mellitus, coronary artery disease and heart disease].

Authors:  Martin Clodi; Christoph Säly; Friedrich Hoppichler; Michael Resl; Clemens Steinwender; Bernd Eber
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

Review 2.  Assessing Cardiovascular Risk and Testing in Type 2 Diabetes.

Authors:  Anum Saeed; Christie M Ballantyne
Journal:  Curr Cardiol Rep       Date:  2017-03       Impact factor: 2.931

3.  Endothelial markers may link kidney function to cardiovascular events in type 2 diabetes.

Authors:  Christina Maier; Martin Clodi; Stephanie Neuhold; Michael Resl; Marie Elhenicky; Rudolf Prager; Deddo Moertl; Guido Strunk; Anton Luger; Joachim Struck; Richard Pacher; Martin Hülsmann
Journal:  Diabetes Care       Date:  2009-06-29       Impact factor: 19.112

Review 4.  [Heart failure in diabetes].

Authors:  Michael Resl; Martin Hülsmann; Richard Pacher; Martin Clodi
Journal:  Wien Med Wochenschr       Date:  2009

5.  Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study.

Authors:  Piercarlo Ballo; Irene Betti; Alessandro Barchielli; Daniela Balzi; Gabriele Castelli; Leonardo De Luca; Mihai Gheorghiade; Alfredo Zuppiroli
Journal:  Clin Res Cardiol       Date:  2015-11-07       Impact factor: 5.460

6.  N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.

Authors:  Anna H Price; Paul Welsh; Christopher J Weir; Insa Feinkohl; Christine M Robertson; Joanne R Morling; Stela McLachlan; Mark W J Strachan; Naveed Sattar; Jackie F Price
Journal:  Diabetologia       Date:  2014-09-18       Impact factor: 10.122

Review 7.  NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes.

Authors:  Marcus Vinicius Bolivar Malachias; Magnus Olof Wijkman; Marcello Casaccia Bertoluci
Journal:  Diabetol Metab Syndr       Date:  2022-05-03       Impact factor: 5.395

8.  Mechanisms underlying diabetic cardiomyopathy: From pathophysiology to novel therapeutic targets.

Authors:  Shuo Cong; Chrishan J A Ramachandra; Kp Myu Mai Ja; Jonathan Yap; Winston Shim; Lai Wei; Derek J Hausenloy
Journal:  Cond Med       Date:  2020-05-05

9.  N-terminal probrain natriuretic peptide is a stronger predictor of cardiovascular mortality than C-reactive protein and albumin excretion rate in elderly patients with type 2 diabetes: the Casale Monferrato population-based study.

Authors:  Graziella Bruno; Andrea Landi; Federica Barutta; Giuseppe Ghezzo; Claudio Baldin; Laura Spadafora; Andrea Schimmenti; Tania Prinzis; Paolo Cavallo Perin; Gabriella Gruden
Journal:  Diabetes Care       Date:  2013-04-05       Impact factor: 19.112

10.  Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Mauro Gori; Deepak K Gupta; Brian Claggett; Elizabeth Selvin; Aaron R Folsom; Kunihiro Matsushita; Natalie A Bello; Susan Cheng; Amil Shah; Hicham Skali; Orly Vardeny; Hanyu Ni; Christie M Ballantyne; Brad C Astor; Barbara E Klein; David Aguilar; Scott D Solomon
Journal:  Diabetes Care       Date:  2016-01-06       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.